Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BYFrontiers in cardiovascular medicine

Case Report: Recurrent Kounis syndrome complicated with acute coronary stent thrombosis

  1. 1Department of Cardiology, People’s Hospital of Fengjie , ,

Abstract

Background: Kounis syndrome manifests as an acute coronary syndrome induced by an allergic or hypersensitivity reaction. Kounis syndrome consists of three types: Type I is characterized by coronary artery spasm in normal or near-normal arteries, Type II by the rupture of coronary artery plaques, and Type III by the formation of thrombus within the coronary artery stent. Recurrent episodes of Kounis syndrome are uncommon in clinical practice. We herein report a case of recurrent Kounis syndrome, in which the second episode presented as Type III Kounis syndrome.

Case presentation: We report a patient who experienced two acute coronary events triggered by Kounis syndrome within approximately one month—an uncommon presentation. One episode manifested as chest pain accompanied by tongue swelling, and was diagnosed as Type II Kounis syndrome and treated with cetirizine for anti-allergic purposes. The second episode occurred about one month later with persistent chest pain and recurrent tongue swelling, and coronary angiography confirmed acute coronary stent thrombosis. Taken together with the allergic manifestation (tongue swelling) accompanying both events, the second episode fulfilled the criteria for Type III Kounis syndrome. Subsequently, we performed emergency procedures to open the blocked coronary artery and administered glucocorticoid therapy. The patient's symptoms improved.

Conclusion: Despite antihistamine therapy with cetirizine in the first episode, this patient still developed subsequent stent-related thrombosis. This case highlights that combined anti-allergic therapy including glucocorticoids may be considered at an early stage for Kounis syndrome patients with unidentified allergens, to mitigate potential allergic-mediated cardiac risk. Nevertheless, we cannot conclude glucocorticoids definitely prevent stent thrombosis, as avoidance of unrecognized allergens may also contribute to clinical improvement.

Related

  1. May Thurner Syndrome (MTS), A Rare Cause of Recurrent Lower Extremity Deep Venous Thrombosis (DVT)
    Amir Rashid, Karamat Ali, Attia Khaliq +1
    Pakistan Armed Forces Medical JournalPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaDOAJ
  2. Atrial fibrillation cryoablation complicated by diffuse coronary artery vasospasm and cardiac arrest: a case report
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Right Coronary Artery Thrombosis Causing ST-Elevation Myocardial Infarction After a Coronary Artery Disease Reporting and Data System Score of 0, With Disseminated Intravascular Coagulation During Idiopathic Acute Pancreatitis: A Case Report
    Aoumar G Chamma, Wendy Saliba, Linda Chamma
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Hypertrophic obstructive cardiomyopathy complicated by severe midventricular obstruction treated with percutaneous transluminal septal myocardial ablation using simultaneous contrast imaging with left ventriculography and coronary angiography: a case report
    European heart journal. Case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Staphylococcus aureus–associated pyomyositis complicated by deep vein thrombosis and septic pulmonary embolism in a malnourished child: a case report
    Tesfa Gebremeskel, Nuri Mama, Mesfin Wubishet +1
    BMC PediatricsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsPMCDOAJ
BibTeX
@article{li2026case,
  title = {{Case Report: Recurrent Kounis syndrome complicated with acute coronary stent thrombosis}},
  author = {Yong Li and Chuanwen Jiang and Xiaojun Zhou and Qidong Cao},
  journal = {Frontiers in cardiovascular medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1948247},
  url = {https://europepmc.org/article/PMC/PMC13690657},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Case Report: Recurrent Kounis syndrome complicated with acute coronary stent thrombosis
AU  - Yong Li
AU  - Chuanwen Jiang
AU  - Xiaojun Zhou
AU  - Qidong Cao
PY  - 2026
DA  - 2026/10/09
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.1948247
UR  - https://europepmc.org/article/PMC/PMC13690657
AB  - Background: Kounis syndrome manifests as an acute coronary syndrome induced by an allergic or hypersensitivity reaction. Kounis syndrome consists of three types: Type I is characterized by coronary artery spasm in normal or near-normal arteries, Type II by the rupture of coronary artery plaques, and Type III by the formation of thrombus within the coronary artery stent. Recurrent episodes of Kounis syndrome are uncommon in clinical practice. We herein report a case of recurrent Kounis syndrome, in which the second episode presented as Type III Kounis syndrome.  Case presentation: We report a patient who experienced two acute coronary events triggered by Kounis syndrome within approximately one month—an uncommon presentation. One episode manifested as chest pain accompanied by tongue swelling, and was diagnosed as Type II Kounis syndrome and treated with cetirizine for anti-allergic purposes. The second episode occurred about one month later with persistent chest pain and recurrent tongue swelling, and coronary angiography confirmed acute coronary stent thrombosis. Taken together with the allergic manifestation (tongue swelling) accompanying both events, the second episode fulfilled the criteria for Type III Kounis syndrome. Subsequently, we performed emergency procedures to open the blocked coronary artery and administered glucocorticoid therapy. The patient's symptoms improved.  Conclusion: Despite antihistamine therapy with cetirizine in the first episode, this patient still developed subsequent stent-related thrombosis. This case highlights that combined anti-allergic therapy including glucocorticoids may be considered at an early stage for Kounis syndrome patients with unidentified allergens, to mitigate potential allergic-mediated cardiac risk. Nevertheless, we cannot conclude glucocorticoids definitely prevent stent thrombosis, as avoidance of unrecognized allergens may also contribute to clinical improvement.
SN  - 2297-055X
ER  -